Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED50 of oliceridine with propofol for analgesia in elderly men undergoing transperineal prostate biopsy
ChiCTR2600117341Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of Jiangnan University
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of oliceridine (2 arms), sponsored by Affiliated Hospital of Jiangnan University. Primary endpoint: Oliceridine dose at anesthesia induction. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
oliceridine
Beyond the preview
Go deeper on ChiCTR2600117341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600117341.